betaxolol has been researched along with endothelin-1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alder, V; Buckland, L; Cringle, S; Su, EN; Yu, DY; Yu, P | 1 |
| Kim, DM; Kim, JH; Park, WC | 1 |
| Araie, M; Fukaya, Y; Ishii, K; Matsuo, H; Sakaki, H; Tanaka, S; Waki, M | 1 |
| Funada, J; Kitakaze, M; Sekiya, M; Sueda, S; Suzuki, J; Tsuruoka, T; Watanabe, K | 1 |
4 other study(ies) available for betaxolol and endothelin-1
| Article | Year |
|---|---|
Preservation of vasoactive properties of human retinal arteries after cryopreservation.
Topics: Aged; Animals; Betaxolol; Cryopreservation; Endothelin-1; Humans; Middle Aged; Nimodipine; Retinal Artery; Swine; Tissue Preservation; Vasodilation; Vasodilator Agents | 1998 |
Effect of betaxolol on impaired choroidal blood flow after intravitreal injection of endothelin-1 in albino rabbits.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Pressure; Choroid; Endothelin-1; Instillation, Drug; Intraocular Pressure; Rabbits; Regional Blood Flow | 2002 |
Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation.
Topics: Administration, Topical; Animals; Anterior Eye Segment; Autoradiography; Betaxolol; Calcium; Calcium Channel Blockers; Calcium Channels; Endothelin-1; Eye; Injections, Intravenous; Ophthalmic Solutions; Piperazines; Pyridines; Rabbits; Retina; Retinal Artery; Solubility; Vasoconstriction; Vasodilator Agents | 2003 |
Beneficial effects of betaxolol, a selective antagonist of beta-1 adrenoceptors, on exercise-induced myocardial ischemia in patients with coronary vasospasm.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Aged; Betaxolol; Biomarkers; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vasospasm; Drug Evaluation; Electrocardiography; Endothelin-1; Endothelium, Vascular; Exercise; Exercise Test; Exercise Tolerance; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Motor Activity; Myocardial Ischemia; Nitric Oxide; Oxygen Consumption; Severity of Illness Index; Treatment Outcome; Vasoconstriction; Vasodilation | 2003 |